C-reactive protein level indicates AMD risk

Article

People with high blood levels of C-reactive protein may be at higher risk of developing age-related macular degeneration.

People with high blood levels of C-reactive protein may be at higher risk of developing age-related macular degeneration (AMD), according to a report published in October issue of Archives of Ophthalmology.

Sharmila S. Boekhoorn and colleagues from the Erasmus Medical Centre, Rotterdam, the Netherlands collected blood samples and took photographs of the eyes of more than 4,900 people at risk from AMD and followed the group for an average of 7.7 years. During this period, 658 subjects were diagnosed with AMD; 561 with initial stage AMD and 97 with advanced AMD.

It was found that as a person's C-reactive protein level increased the person became more and more likely to develop AMD.

The researchers suggest that lowering C-reactive protein levels may help decrease the risk of developing AMD.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.